Koala Vaccine Approved in Australia
MELBOURNE, Australia — A regulator has given the green light for a groundbreaking vaccine designed to protect koalas from chlamydia infections. This disease significantly impacts the reproductive health of these beloved animals, contributing to infertility and death. Koalas are already listed as endangered in certain areas of Australia.
The innovative single-dose vaccine was created by researchers at the University of the Sunshine Coast in Queensland, under the direction of microbiologist Peter Timms, who has dedicated over ten years to this research.
Findings indicated that the vaccine not only lowers the chances of koalas developing chlamydia symptoms but also reduces mortality rates from the disease in wild populations by at least 65%.
With this recent approval from Australia’s veterinary medicine regulator, the vaccine will now be available for use in wildlife hospitals, veterinary clinics, and directly in the field to help protect the most vulnerable koalas, Timms announced on Wednesday.
“We recognized that a single-dose vaccine — with no requirement for boosters — was crucial in curbing the swift and devastating spread of this disease,” Timms noted. “Chlamydia has been responsible for as much as half of all koala deaths across various wild populations in Australia.”
He added that certain koala colonies are alarmingly close to local extinction, especially in southeastern Queensland and New South Wales, where infection rates can hover around 50%, and in some cases, reach up to 70%.
However, Deborah Tabart, chair of the Australian Koala Foundation, believes that resources allocated for vaccinating koalas should instead be focused on protecting their habitat.
“Honestly, how can anyone think we can vaccinate 100,000 animals? It’s quite absurd,” Tabart remarked. Her organization estimates there are now fewer than 100,000 koalas left in the wild. In contrast, the government-supported National Koala Monitoring Program estimated the number to be between 224,000 and 524,000 last year.
“While I acknowledge that chlamydia is a serious issue, we must recognize that these animals are suffering because their habitat is disappearing,” she stated.
On the other hand, the Queensland Conservation Council, representing over 50 environmental groups statewide, welcomed the vaccine. However, their director, Dave Copeman, emphasized the importance of habitat preservation.
“This is genuinely positive news. Chlamydia is one of the significant factors harming koala populations,” Copeman said. “But even with perfect management of chlamydia, koalas will still face risks due to ongoing habitat destruction.”
Koalas are classified as endangered in Queensland, New South Wales, and the Australian Capital Territory, with habitat loss primarily driven by wildfires and urban expansion. The chlamydia infection can lead to urinary tract infections, infertility, blindness, and ultimately death.
Treatments using antibiotics can disrupt a koala’s ability to digest eucalyptus, their sole food source, leading to starvation, according to university statements.
This research has been supported by both federal and state governments in New South Wales and Queensland. Federal Environment Minister Murray Watt noted that the development of the vaccine was partially funded through a 76 million Australian dollar ($50 million) Saving Koalas Fund.
“We understand that koalas require assistance in combating diseases like chlamydia, which severely impacts their reproductive health,” Watt stated.
Koalas remain one of Australia’s most iconic species, sharing their home with creatures like wombats and kangaroos. Typically, they spend hours eating and resting in eucalyptus trees, utilizing their unique paws to grip and climb.
Yet, Australian koala populations have plummeted dramatically in the last twenty years. Facing multiple threats—including disease, habitat loss, climate change, and vehicle collisions—koalas could face extinction by 2050, as suggested in a 2020 government assessment.
